GL1X · GenesisL1 explorer

MolNFT v1 · #169478 · protein

Kpc-2 N170A mutant bound to hydrolyzed ampicillin at 1.65 a

6XD7: “Kpc-2 N170A mutant bound to hydrolyzed ampicillin at 1.65 a”. X-ray diffraction, 1 ligand (ZZ7). MolNFT v1 #169478 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6XD7
Type
protein
Length
266 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q9F663
Ligands
ZZ7

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein266—Q9F663

Ligands and binding sites

  • ZZ7 · (2R,4S)-2-[(R)-{[(2R)-2-amino-2-phenylacetyl]amino}(carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6XD7 · KPC-2 N170A mutant bound to hydrolyzed ampicillin at 1.65 A · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9F663 · AlphaFold monomer V2.0 prediction for carbapenem-hydrolyzing beta- lactamase kpc (Q9F663) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.